CD8+ T cell recall cytotoxicity during antiretroviral therapy is associated with limited HIV-1 reservoir size and activity
This study reveals that a subset of people with HIV on antiretroviral therapy possess highly functional CD8+ T cells capable of targeting autologous viral reservoirs, a phenomenon associated with smaller, less active reservoirs and the attenuation of viral rebound during treatment interruption, thereby highlighting the potential of immunotherapies to achieve durable HIV remission.